Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$1.09
NASDAQ
Change (%)
 Stock is Down 0.01 (0.91%)
Volume
266,758
01/19/18      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
01/04/18OvaScience to Present at the 36th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 4, 2018-- OvaScience℠ (NASDAQ: OVAS), a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility, today announced that Christopher Kroeger, M.D., Chief Executive Officer of OvaScience, will present a corporate overview at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018 at 11:00 a.m. PT (2:00 p.m. ET)... 
Printer Friendly Version
01/03/18OvaScienceSM Announces Corporate Update
– Reporting Safety Data from First 20 Patients in Phase 1 Study of the OvaPrimeSM Treatment; Advancing OvaPrime into Phase 1b/2a Multi-Center Trial – – James Lillie, Ph.D., Joining as Chief Scientific Officer to Lead Ongoing Preclinical Research & Development Efforts – – Improving Financial Position Through Corporate Restructuring – WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 3, 2018-- OvaScience (NASDAQ:OVAS), a company focused ... 
Printer Friendly Version
11/02/17OvaScience Reports Third Quarter 2017 Financial Results
– Initial Safety Data from First 20 Patients in OvaPrime℠ Clinical Trial Expected by Year-End – – Granted Exclusive License to IVF Japan Group to Offer the AUGMENT℠ Treatment in Japan – – Conference Call Today at 4:30 p.m. ET – WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 2, 2017-- OvaScience℠ (NASDAQ:OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options for women, today... 
Printer Friendly Version
10/26/17OvaScience to Host Third Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 26, 2017-- OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Thursday, November 2, 2017 to discuss third quarter 2017 financial results and provide a general corporate update. The conference call may be accessed by dialing +1-888-424-8151 for U.S. c... 
Printer Friendly Version

Upcoming Events

More »
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources